Outset Medical (OM) Competitors $0.81 -0.01 (-0.98%) Closing price 04:00 PM EasternExtended Trading$0.84 +0.03 (+3.33%) As of 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends OM vs. INFU, LAKE, TLSI, SGHT, PDEX, LNSR, ZJYL, SRTS, ECOR, and TELAShould you be buying Outset Medical stock or one of its competitors? The main competitors of Outset Medical include InfuSystem (INFU), Lakeland Industries (LAKE), TriSalus Life Sciences (TLSI), Sight Sciences (SGHT), Pro-Dex (PDEX), LENSAR (LNSR), Jin Medical International (ZJYL), Sensus Healthcare (SRTS), electroCore (ECOR), and TELA Bio (TELA). These companies are all part of the "medical equipment" industry. Outset Medical vs. InfuSystem Lakeland Industries TriSalus Life Sciences Sight Sciences Pro-Dex LENSAR Jin Medical International Sensus Healthcare electroCore TELA Bio InfuSystem (NYSE:INFU) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, community ranking, profitability and media sentiment. Do insiders and institutionals have more ownership in INFU or OM? 71.1% of InfuSystem shares are held by institutional investors. 10.2% of InfuSystem shares are held by insiders. Comparatively, 3.5% of Outset Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Do analysts recommend INFU or OM? InfuSystem presently has a consensus price target of $13.00, suggesting a potential upside of 60.10%. Outset Medical has a consensus price target of $4.50, suggesting a potential upside of 459.70%. Given Outset Medical's higher probable upside, analysts plainly believe Outset Medical is more favorable than InfuSystem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InfuSystem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 2 Strong Buy rating(s) 4.00Outset Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Does the MarketBeat Community favor INFU or OM? Outset Medical received 18 more outperform votes than InfuSystem when rated by MarketBeat users. However, 100.00% of users gave InfuSystem an outperform vote while only 38.71% of users gave Outset Medical an outperform vote. CompanyUnderperformOutperformInfuSystemOutperform Votes6100.00% Underperform VotesNo VotesOutset MedicalOutperform Votes2438.71% Underperform Votes3861.29% Is INFU or OM more profitable? InfuSystem has a net margin of 1.12% compared to Outset Medical's net margin of -122.84%. InfuSystem's return on equity of 2.78% beat Outset Medical's return on equity.Company Net Margins Return on Equity Return on Assets InfuSystem1.12% 2.78% 1.41% Outset Medical -122.84%-164.92%-43.27% Which has stronger earnings & valuation, INFU or OM? InfuSystem has higher revenue and earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInfuSystem$132.78M1.30$870K$0.06135.33Outset Medical$114.73M0.38-$172.80M-$2.76-0.29 Which has more volatility and risk, INFU or OM? InfuSystem has a beta of 1.53, suggesting that its share price is 53% more volatile than the S&P 500. Comparatively, Outset Medical has a beta of 2.05, suggesting that its share price is 105% more volatile than the S&P 500. Does the media favor INFU or OM? In the previous week, Outset Medical had 4 more articles in the media than InfuSystem. MarketBeat recorded 4 mentions for Outset Medical and 0 mentions for InfuSystem. Outset Medical's average media sentiment score of 0.69 beat InfuSystem's score of 0.00 indicating that Outset Medical is being referred to more favorably in the news media. Company Overall Sentiment InfuSystem Neutral Outset Medical Positive SummaryInfuSystem beats Outset Medical on 13 of the 19 factors compared between the two stocks. Get Outset Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OM vs. The Competition Export to ExcelMetricOutset MedicalElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$42.69M$3.68B$5.58B$9.11BDividend YieldN/A1.62%5.36%3.98%P/E Ratio-0.2919.0988.4717.54Price / Sales0.3865.361,263.0482.41Price / CashN/A39.3144.3037.67Price / Book0.334.015.104.72Net Income-$172.80M$94.49M$117.69M$224.52M7 Day Performance-6.51%-0.82%0.92%-0.56%1 Month Performance-31.28%2.80%10.21%4.62%1 Year Performance-75.19%3.24%26.31%18.89% Outset Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMOutset Medical1.9386 of 5 stars$0.81-1.0%$4.50+454.2%-76.8%$43.60M$114.73M-0.29520Short Interest ↑INFUInfuSystemN/A$8.27+1.8%$13.00+57.2%N/A$175.82M$125.79M137.86410LAKELakeland Industries4.8242 of 5 stars$23.10+1.6%$27.50+19.0%+30.3%$171.17M$124.69M-256.671,750Short Interest ↑TLSITriSalus Life Sciences3.8283 of 5 stars$5.30+2.3%$11.79+122.4%-45.3%$161.60M$18.51M-2.13106Insider TradeNews CoveragePositive NewsGap UpHigh Trading VolumeSGHTSight Sciences3.8061 of 5 stars$2.92-0.3%$4.62+58.2%-35.2%$148.21M$79.54M-2.86210Analyst ForecastPDEXPro-Dex3.5242 of 5 stars$41.27+1.5%$52.00+26.0%+92.3%$134.54M$53.84M26.80140Earnings ReportInsider TradeLNSRLENSAR1.1417 of 5 stars$10.70+13.6%$8.00-25.2%+231.0%$124.23M$42.16M-7.33110Positive NewsHigh Trading VolumeZJYLJin Medical InternationalN/A$0.79-11.2%N/A-99.6%$122.47M$19.82M0.00245Short Interest ↓News CoverageGap UpSRTSSensus Healthcare3.355 of 5 stars$6.79-4.9%$12.50+84.1%+93.6%$111.29M$24.41M11.9140Upcoming EarningsShort Interest ↑News CoverageECORelectroCore2.9787 of 5 stars$16.49-3.1%$25.00+51.6%+104.7%$108.01M$16.03M-9.0150Short Interest ↓News CoverageTELATELA Bio2.7323 of 5 stars$2.67flat$9.25+246.4%-60.4%$105.17M$58.45M-1.58120 Related Companies and Tools Related Companies INFU Competitors LAKE Competitors TLSI Competitors SGHT Competitors PDEX Competitors LNSR Competitors ZJYL Competitors SRTS Competitors ECOR Competitors TELA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OM) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump’s back in the oval office. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. And he says 2025 could be...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outset Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Outset Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
